Literature DB >> 33882509

Diagnostic delay in axial spondyloarthritis - a past or current problem?

Denis Poddubnyy1,2, Joachim Sieper1.   

Abstract

PURPOSE OF REVIEW: To evaluate recent data on diagnostic delay in axial spondyloarthritis (axSpA), factors affecting the delay, potential ways of early diagnosis improvement, and risks associated with early diagnostic approaches. RECENT
FINDINGS: Although axSpA can be diagnosed nowadays within the first months after symptom onset, the diagnostic delay remains with several years still remarkably high in many parts of the world. Female gender, human leukocyte antigen-B27 negativity, and younger age at disease onset are among factors associated with a delayed referral to a rheumatologist and consequently with a larger diagnostic delay. Early referral algorithms are helpful in the identification of patients with a high probability of axSpA among patients with chronic back pain. A careful diagnostic evaluation with correct imaging interpretation is required to avoid misdiagnosis of axSpA in patients with unspecific back pain.
SUMMARY: The diagnostic delay is still considerable in axSpA. The ways to early diagnosis in axSpA are well defined. Imaging findings should always be considered in the clinical context to avoid axSpA misdiagnosis.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33882509     DOI: 10.1097/BOR.0000000000000802

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  4 in total

1.  Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey.

Authors:  Salvatore D'Angelo; Antonella Afeltra; Fabiola Atzeni; Elena Baldissera; Maurizio Caminiti; Francesco Ciccia; Maria Antonietta D'Agostino; Lorenzo Dagna; Gian Luca Erre; Franco Franceschini; Enrico Fusaro; Roberto Giacomelli; Elisa Gremese; Giuliana Guggino; Claudia Lomater; Ennio Lubrano; Angela Anna Padula; Giuseppa Pagano Mariano; Romualdo Russo; Piercarlo Sarzi Puttini; Raffaele Scarpa; Carlo Selmi; Enrico Tirri; Stefano Ferri; Florenzo Iannone
Journal:  Front Med (Lausanne)       Date:  2022-05-24

2.  CXCL12/CXCR4-Rac1-mediated migration of osteogenic precursor cells contributes to pathological new bone formation in ankylosing spondylitis.

Authors:  Haowen Cui; Zihao Li; Siwen Chen; Xiang Li; Dongying Chen; Jianru Wang; Zemin Li; Wenjun Hao; Fangling Zhong; Kuibo Zhang; Zhaomin Zheng; Zhongping Zhan; Hui Liu
Journal:  Sci Adv       Date:  2022-04-06       Impact factor: 14.136

Review 3.  A glance into the future of diagnosis and treatment of spondyloarthritis.

Authors:  Victoria Navarro-Compán; Joerg Ermann; Denis Poddubnyy
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-22       Impact factor: 3.625

4.  Responding to and Driving Change in Rheumatology: Report from the 12th International Immunology Summit 2021.

Authors:  Renaud Felten; Nicolas Rosine
Journal:  Rheumatol Ther       Date:  2022-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.